ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Ticker Update

Updates

SUB-TYPE: CLASS 2 RECALL

24th July 2019

Class 2 Recall on Bisacodyl Tab 5mg X 1000

Chanelle Medical is recalling the below batch because a small number of packs have been found to contain tablets which are stuck together, with mould observed on some tablets. The mould has been identified as a Penicillium species. It is unlikely that affected tablets will have got to patient level as the sticking is noticeable on opening the pack..

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
8096331BISACODYL TAB 5MG X 1000CHANELLE MEDICAL25074A

For stock enquiries please contact David Hammond, General Manager, Healthcare Pharma: Tel: 01233 822 297 Email: rp@healthcarepharma.co.uk.

For medical information enquiries please contact Anne Dougherty, Operations Director, Panacea Pharma Projects, Isle of Man: Tel: 44-1624 672777 Email: anne.dougherty@panacea.im.

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 4 CAUTION IN USE

11th July 2019

Class 4 Caution in Use on Emerade 150, 300, 500 Micrograms Pfs

Bausch & Lomb UK limited has informed us of a risk of Emerade product failing to deliver a dose of adrenaline from the syringe due to blockage of the needle.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
3849221EMERADE 150 AUTO-INJECTORBAUSCH & LOMB UKALL STOCK
3849239EMERADE 300 AUTO-INJECTORBAUSCH & LOMB UKALL STOCK
3849247EMERADE 500 AUTO-INJECTORBAUSCH & LOMB UKALL STOCK

Please note that Alliance Healthcare do not stock and as this is a caution in use only we are not accepting stock returns.

For stock enquiries please contact Bausch & Lomb Customer Services: Tel: 0208 781 2991 Email: Pharma_CS@bausch.com.

For medical information enquiries please contact Lizanne Kombrink, Pharmacovigilance and Medical Information Officer: Tel: 0208 781 5523 Email: Pharmacovigilance.UK@bausch.com.

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 4 CAUTION IN USE

03rd July 2019

Class 4 Recall on Potassium Chloride

Baxter Healthcare Limited has informed us that a quality defect has been identified with the above products where the front panel of a small number of infusion bags was found to be missing the red text.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
ALLIANCE DO NOT STOCKPOTASSIUM CHLORIDE 0.15% W/V AND GLUCOSE 10% W/V SOLUTION FOR INFUSION, 500MLBAXTER HEALTHCARE LIMITEDPLEASE REFER TO THE ABOVE LINK FOR BATCH NUMBERS
ALLIANCE DO NOT STOCKPOTASSIUM CHLORIDE 0.15% W/V AND SODIUM CHLORIDE 0.9% W/V SOLUTION FOR INFUSION – BP, 1000MLBAXTER HEALTHCARE LIMITEDPLEASE REFER TO THE ABOVE LINK FOR BATCH NUMBERS
ALLIANCE DO NOT STOCKPOTASSIUM CHLORIDE 0.3% W/V AND SODIUM CHLORIDE 0.9% W/V SOLUTION FOR INFUSION, 1000MLBAXTER HEALTHCARE LIMITEDPLEASE REFER TO THE ABOVE LINK FOR BATCH NUMBERS

For stock control enquiries and medical Information enquiries please contact Baxter by email: uk_shs_qa_complaints@baxter.com or by telephone: 01604 704 603 (Baxter reference number: FA-2019-026).

Please note that Alliance Healthcare do not stock and as this is a caution in use only we are not accepting stock returns.

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: COMPANY-LED RECALL

24th June 2019

Company-Led Recall on DOCETAXEL VIAL 20MG PFZ 2ML & DOCETAXEL VIAL 160MG PFZ 16ML

Pfizer UK Limited is recalling the below batches. This is because routine stability testing has identified that levels of a known impurity, 10-oxo-docetaxel, may exceed the acceptable level at end of shelf-life.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
8120875DOCETAXEL VIAL 20MG PFZ 2MLPFIZER LTDS0150518
8120867DOCETAXEL VIAL 160MG PFZ 16MLPFIZER LTDS0390218
S0120218

 

Please do not consolidate any stock for return. All returns must be from the original delivery address. Any product(s) returned from non-Pfizer accounts will be retained by the distribution centre and not returned. Credit for these returned products must be obtained from the supplier from where the product was purchased.

All Stock must be returned to Alliance Healthcare before the 19th September 2019.

For medical information please contact Pfizer Medical Information Department on 01304 616161

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

13th May 2019

Class 2 Recall on Co-Amoxiclav 125 Mg/31.25 Mg/5 Ml & 25 Mg/62.5 Mg/5 Ml Powder For Oral Suspension

Sandoz Ltd. have been notified of a potential packaging problem relating to poor seal adherence which could cause clumping of the powder within the bottle. A poor bottle seal could lead to degradation of the clavulanic acid within the powder and could potentially render the product ineffective..

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
1086271CO-AMOXICLAV SF 125/31.25MGSANDOZ LTDHT6202
HT7923
1117290CO-AMOXICLAV 31/125MG/5MLSANDOZ LTDHT6202
HT7923
1086289CO-AMOXICLAV 250/62MGSANDOZ LTDHT6202
HT7923
1117308CO-AMOXICLAV SF 250/62.5MGSANDOZ LTDHT6202
HT7923

For enquiries relating to stock returns please contact Sandoz Limited Customer Services on 01276 698607 or email sales.sandoz-gb@sandoz.com

For Medical information enquiries, please contact Sandoz Medical Information Team on 01276 698101or email sandozgb@EU.propharmagroup.com

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 4 CAUTION IN USE

29th April 2019

Class 4 Caution in Use on Prednisolone Tab 5mg

Genesis Pharmaceuticals Ltd has informed us that there is an error on the Braille for the above batches which means that the strength reads as 1mg instead of 5mg. The printed text is correct on all packaging.

Please visit the: MHRA website for more details on this drug alert

The affected products' details are as follows:

For further information please contact Genesis Pharmaceuticals Ltd, tel. 020 7201 0400.

This is a caution in use only and therefore we are not accepting stock returns.

If you have any questions, then please contact your local Service Centre Customer Services team.

PIP CodeProduct DescriptionSupplierAffected Batches
1110840PREDNISOLONE TAB 5MG ALMALMUS PHARMACEUTICALS LTD1809653
1809654
1809655
1809656
1809657
1057363PREDNISOLONE TAB 5MG ACTACCORD SCHEME1809653
1809654
1809655
1809656
1809657
1057132PREDNISOLONE TAB 5MG TEVTEVA UK LTD1809653
1809654
1809655
1809656
1809657
1052893PREDNISOLONE TAB 5MG CPWOCKHARDT ETHICAL(MOV)1809653
1809654
1809655
1809656
1809657

SUB-TYPE: CLASS 2 RECALL

26th April 2019

Class 2 Recall on Valsartan

Teva UK Limited and Mylan are recalling some Valsartan containing products including certain batches supplied by Teva UK Limited and all unexpired batches supplied by Mylan.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionLiveryAffected Batches
8466179VALSARTAN TAB 40MGTEVA UK LIMITED100350
100938
101776
1166909VALSARTAN TAB 40MG TEVTEVA UK LIMITED100350
100938
101776
1167535VALSARTAN TAB 40MG GUKTEVA UK LIMITED100350
100938
101776
1161546VALSARTAN TAB 40MG ACTTEVA UK LIMITED100350
100938
101776
8466245VALSARTAN TAB 320MGTEVA UK LIMITED100433
101777
1166917VALSARTAN TAB 320MG TEVTEVA UK LIMITED100433
101777
1173152VALSARTAN TAB 320MG ACTTEVA UK LIMITED100433
101777
1166958VALSARTAN HCTZ TAB80/12.5MG TEVTEVA UK LIMITED6P601163
6P606333
0001584
0002626
0002627
0003214
0004744
8466203VALSARTAN HCTZ TAB 80MG/12.5MGTEVA UK LIMITED6P601163
6P606333
0001584
0002626
0002627
0003214
0004744
1161520VALSARTAN HCT TAB 80/12.5MG ACTTEVA UK LIMITED6P601163
6P606333
0001584
0002626
0002627
0003214
0004744
8466161VALSARTAN HCTZ TAB 160MG/25MGTEVA UK LIMITED6P601084
6P606270
0000350
0000352
0001997
0002338
0003615
1166941VALSARTAN HCT TAB 160/25MG TEVTEVA UK LIMITED6P601084
6P606270
0000350
0000352
0001997
0002338
0003615
1162353VALSARTAN HCT TAB 160/25MG ACTTEVA UK LIMITED6P601084
6P606270
0000350
0000352
0001997
0002338
0003615
8466195VALSARTAN HCTZ TAB 160MG/12.5MGTEVA UK LIMITED6P607166
0000426
0001520
0001521
0002298
0003663
0004670
1166966VALSARTAN HCT TAB 160/12.5MG TEVTEVA UK LIMITED6P607166
0000426
0001520
0001521
0002298
0003663
0004670
1161538VALSARTAN HCT TAB 160/12.5MG ACTTEVA UK LIMITED6P607166
0000426
0001520
0001521
0002298
0003663
0004670
1167626VALSARTAN CAPSULES 80MG ACTMYLANALL STOCK
1166883VALSARTAN CAP 80MG TEVMYLANALL STOCK
8466229VALSARTAN CAP 80MGMYLANALL STOCK
1166214VALSARTAN CAP 80 MG GUKMYLANALL STOCK
1166875VALSARTAN CAP 40MG TEVMYLANALL STOCK
1167618VALSARTAN CAP 40MG ACTMYLANALL STOCK
8466237VALSARTAN CAP 40MGMYLANALL STOCK
1166206VALSARTAN CAP 40 MG GUKMYLANALL STOCK
1166891VALSARTAN CAP 160MG TEVMYLANALL STOCK
8466211VALSARTAN CAP 160MGMYLANALL STOCK
1166222VALSARTAN CAP 160 MG GUKMYLANALL STOCK
1167634VALSARTAN CAPSULES 160MG ACTMYLANALL STOCK

Teva UK Limited

For stock control: general.enquiries@tevauk.com

For medical information enquiries: medinfo@tevauk.com

 

Mylan

For stock control: mguk_customer.services@mylan.co.uk, 01707 853100

For medical information enquiries: info@mylan.co.uk, 01707 853 000, Option 1

Any stock returned after the 30th April 2019 will not receive credit.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 4 CAUTION IN USE

05th April 2019

Class 4 Recall on Zoledronic acid 5mg solution for infusion

Ranbaxy (UK) Ltd a Sun Pharmaceutical Company, has informed us that some packs from the above batch contain a Patient Information Leaflet (PIL) for Temozolomide 180mg Capsules..

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionLiveryAffected Batch

1186964Zoledronic acid 5mg solution for infusionRanbaxy (UK) LtdJKT1576A

For any enquiries, please contact Ranbaxy / Sun Pharmaceuticals customer services team: Tel: 020 8848 5050; email: cserv.uk@sunpharma.com.
 

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

This is a caution in use only and therefore we are not accepting stock returns.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

05th December 2018

Class 2 Recall on Ranitidine 150mg & 300mg Tabs Accord Healthcare

Accord Healthcare are recalling all unexpired stock of the above products from pharmacies and wholesalers as a precautionary measure due to possible contamination with an impurity Nnitrosodimethylamine (NDMA) which has genotoxic and carcinogenic potential.

 

Please visit the: MHRA website for more details on this drug alert.

 

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
7056195RANITIDINE TAB 150MGAccord HealthcareALL STOCK
1069087RANITIDINE TAB 150MGAccord HealthcareALL STOCK
7056203RANITIDINE TAB 300MGAccord HealthcareALL STOCK
1069046RANITIDINE TAB 300MGAccord HealthcareALL STOCK
1179191RANITIDINE TABS 150MGAccord HealthcareALL STOCK

For stock control enquiries please contact Accords Customer Service team on 0800 373573

For medical information enquiries please contact Accords Pharmacovigilance Department on 01271 385257 or medinfo@accord-healthcare.com

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

27th November 2017

Class 2 Recall on Paracetamol 500mg (1000s) M&A Pharma

M & A Pharmachem is recalling the above batches as a precautionary measure, because a small number of pots from some batches have been found to contain discoloured tablets due to fungal contamination. The fungus has been identified as Penicillium citrinum. It is unlikely that any affected tablets will have got to patient level as the discolouration is noticeable on opening affected packs.

 

Please visit the: MHRA website for more details on this drug alert.

 

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
7018393PARACETAMOL TAB BP 500MGM&A PHARMACHEMALL STOCK

For enquiries relating to stock returns please contact Pauline Caddick, Responsible Person: pcaddick@mapharmachem.co.uk

For Medical information enquiries, please contact Cristina Parau, Pharmacovigilance Manager: email cparau@mapharmachem.co.uk

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.